window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 18, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

News

NewsDebbie2026-02-23T12:06:10+00:00
  • All
  • Antibody drug conjugates
  • Artificial Intelligence
  • Biologics & Biosimilars
  • Biomanufacturing
  • Biotech
  • Cardiovascular diseases
  • CDMOs & Manufacturing
  • Cell & Gene Therapy
  • Central Nervous System
  • Child & Adolescnt Health
  • Chronic diseases
  • Clinical Development
  • Clinical studies
  • Clinical Trials
  • Data Management
  • Dermatology
  • Diagnostics
  • Digital Health
  • Drug approval
  • Drug Delivery & Formulation
  • Drug Development
  • Drug discovery
  • European biotech
  • Events and Conferences
  • Facilities and infrastructure
  • FDA
  • Funding
  • Gastroenterology
  • Genetic Diseases
  • Genomics and sequencing
  • Global health
  • Healthcare leadership
  • Hematology
  • Immunology
  • Infectious Diseases
  • Ingredients
  • Liver disease
  • Logistics and distribution
  • Manufacturing
  • Market Access & Commercialization
  • Medical devices
  • Mental health
  • Mergers & Acquisitions
  • Metabolic Diseases
  • Middle East
  • Movers & Shakers
  • Neurosciences
  • Obesity
  • Oncology
  • Opthalmology
  • Orphan drugs
  • Orthapaedics
  • Packaging
  • Partnerships & Funding
  • Patient Centricity
  • Peptides
  • Pharmaceuticals and therapeutics
  • Pharmacovigilance
  • Precision medicine
  • Psychadelics
  • Rare Diseases
  • Real world evidence
  • Regulatory Affairs
  • Research & Development
  • Respiratory
  • RNA Therapeutics
  • Single Cell analysis
  • Startups and innovations
  • Supply Chain & Logistics
  • Sustainability
  • Technology and platforms
  • Uncategorised
  • Vaccines
  • Women in Pharma
  • Women's Health
  • Artificial Intelligence,Drug discovery,Funding,Technology and platforms

    DeepCyte raises $1.5M to advance single-cell AI toxicology platform for drug development

    read more
  • Artificial Intelligence,Drug Development,Drug discovery,Research & Development,Technology and platforms

    William Blair highlights Carterra as key player in AI-driven drug discovery shift

    read more
  • Artificial Intelligence,Clinical Development,Genomics and sequencing,Obesity,Precision medicine,Technology and platforms

    23andMe study links genetics to GLP-1 weight loss outcomes and side effects

    read more
  • Clinical Trials,Funding,Opthalmology,Pharmaceuticals and therapeutics,Research & Development

    Life Biosciences raises $80M to advance gene therapy for optic neuropathies

    read more
  • Biomanufacturing,Cell & Gene Therapy,Drug Development,Manufacturing,Partnerships & Funding

    Virica and Fujifilm target AAV manufacturing bottleneck with enhancer collaboration

    read more
  • Clinical Development,Drug Development,Healthcare leadership,Movers & Shakers,Neurosciences,Oncology,Rare Diseases

    Allucent adds strategy leaders to expand therapeutic expertise

    read more
  • Biotech,Funding,Genetic Diseases,Mergers & Acquisitions,Research & Development,RNA Therapeutics

    Circio raises NOK 250M in oversubscribed private placement to advance circRNA gene therapy platform

    read more
  • Clinical Development,Clinical Trials,Data Management,Global health,Real world evidence

    Phesi data highlights 6.7% of global clinical trials affected by Middle East disruption

    read more
  • Healthcare leadership,Mergers & Acquisitions,Movers & Shakers,Pharmaceuticals and therapeutics

    Genmab appoints Margarida Duarte as general manager for Europe and emerging markets

    read more
  • Healthcare leadership,Market Access & Commercialization,Movers & Shakers,Pharmaceuticals and therapeutics,Startups and innovations

    Opella appoints former Reckitt executive Gonzalo Balcazar to lead Europe and Latin America

    read more
  • Biotech,Healthcare leadership,Movers & Shakers,Oncology,Pharmaceuticals and therapeutics,Research & Development

    Orano Med appoints Frederic Desdouits as CEO to advance targeted alpha therapy pipeline

    read more
  • Biotech,Clinical Development,Clinical Trials,Healthcare leadership,Immunology,Movers & Shakers

    Aravax adds allergy specialists to board as peanut therapy advances

    read more
  • Artificial Intelligence,Clinical studies,Drug discovery,Neurosciences,Pharmaceuticals and therapeutics

    AI-derived drug candidate reduces fentanyl intake in preclinical opioid study

    read more
  • Clinical Development,Neurosciences,Partnerships & Funding,Research & Development

    SonoNeu exits stealth as part of $41.3M ARPA-H programme to advance sonogenetics

    read more
  • Clinical Development,Neurosciences,Partnerships & Funding,Research & Development

    AC Immune amends Lilly collaboration on Tau small molecules for Alzheimer’s disease

    read more
  • Biologics & Biosimilars,Clinical Trials,Manufacturing,Oncology,Research & Development

    Anixa Biosciences advances breast cancer vaccine toward Phase 2 with Cytovance manufacturing deal

    read more
Previous123Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • ProQR partners with Ginkgo Bioworks for AI-driven RNA editing development and forms advisory board
    Categories: Artificial Intelligence, Biotech, Drug Development, Drug discovery, Research & Development
  • Weite Oldenziel
    Ofichem unifies CDMO and pharmaceutical supply brands under single identity
    Categories: CDMOs & Manufacturing, Supply Chain & Logistics
  • DeepCyte raises $1.5M to advance single-cell AI toxicology platform for drug development
    Categories: Artificial Intelligence, Drug discovery, Funding, Technology and platforms
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top